Footnotes / Bibliography

Bibliography

1. Elisa, Fabbri. “Inflammageing: chronic inflammation in ageing & cardiovascular,  disease Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. (2018). https://www.nature.com/articles/s41569-018-0064-2

2. Nataša, K.-J. Interplay between NLRP3 inflammasome and autophagy. (2020). https://www.frontiersin.org/articles/10.3389/fimmu.2020.591803/full

3. Justina, P. et al. RAB10: an Alzheimer’s disease resilience locus and potential drug target. (2019). https://www.tandfonline.com/doi/abs/10.2147/CIA.S159148

4. Ridge, P. G. C. M. K. S. H. I. A. C. C. T. M. T. E. J. D. G. M. et al Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience. (2017). https://link.springer.com/article/10.1186/s13073-017-0486-1

5. Irene, M. et al. Age and age-related diseases: role of inflammation triggers and cytokines. (2018). https://www.frontiersin.org/articles/10.3389/fimmu.2018.00586/full

6. Bofeng, L., Arnaud, J. K. K., Tengchuan, J. & Jinhui, T. Pharmacological inhibitors of the NLRP3 inflammasome. (2019). https://www.frontiersin.org/articles/10.3389/fimmu.2019.02538/full

7. Anne-Christine, R., Sandra, L., Thomas, B. & François, Cornélis. “Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families. (2008). https://www.jrheum.org/content/35/5/790.short

8. Fabiana, A., Matteo, P., Irene, A., Rebecca, M. & Annamaria, Iagnocco. “Rheumatoid arthritis: extra-articular manifestations and comorbidities Rheumatoid arthritis: extra-articular manifestations and comorbidities. (2021). https://www.sciencedirect.com/science/article/pii/S1568997221000392

9. Smolen, J. S. R. B. L. J. W. B. G. R. B. M. D. A. K. I. B. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. (2020). https://ard.bmj.com/content/79/6/685.abstract

10. Kaj, B. et al. Alzheimer’s disease. (2016). https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01124-1/fulltext?rss%3Dyes=

11. P., A., P., I. M., S., M. C. & C., R. Oliveira. “Alzheimer’s disease-associated neurotoxic mechanisms and neuroprotective strategies Alzheimer’s disease-associated neurotoxic mechanisms and neuroprotective strategies. (2005). https://www.ingentaconnect.com/content/ben/cdtcnsnd/2005/00000004/00000004/art00007

12. Jessica, W. W. & Vladimir, N. U. α-Synuclein misfolding and Parkinson’s disease. (2012). https://www.sciencedirect.com/science/article/pii/S0925443911002250

13. Yu-He, Y., Nai-Hong, C. & Hong-Bo, W. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson’s disease. (2019). https://www.sciencedirect.com/science/article/pii/S1567576918307641

14. Souvarish, S. et al. Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia. (2019). https://rupress.org/jem/article-abstract/216/6/1411/120381

15. Marjorie, D. la F., Peti, T., Chanitra, T. & Marcela, A. H. Chronic inflammation and cytokines in the tumor microenvironment. (2014). https://onlinelibrary.wiley.com/doi/abs/10.1155/2014/149185

16. Bhesh, R. & Thirumala-Devi, Kanneganti. “NLRP3 inflammasome in cancer and metabolic diseases NLRP3 inflammasome in cancer and metabolic diseases. (2021). https://www.nature.com/articles/s41590-021-00886-5

17. Maria, M. X., Kepeng, W., Adam, J. A., Anthony, T. V. & Beiyan, Z. Macrophage polarization and meta-inflammation. (2018). https://www.sciencedirect.com/science/article/pii/S1931524417302876

18. Cristiane, N. de S., Niels, O. S. C. & Pedro, M. M.-V. The macrophage switch in obesity development. (2016). https://www.frontiersin.org/articles/10.3389/fimmu.2015.00637/full

19. Siegel, R. L. K. D. Miller and Ahmedin Jemal. (2015). https://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=00079235&AN=100399219&h=5buR%2BQ9PU3onW8bcz88X9kKKl25rMo%2BdvMRlB%2BLtJK29bghzpFGUyU%2BDRCS5UKFa8B%2BVI406t0karHYVSAVtkg%3D%3D&crl=c

20. Meng-Chun, T. et al. Role of the NLRP3 inflammasome: insights into cancer hallmarks. (2021). https://www.frontiersin.org/articles/10.3389/fimmu.2020.610492/full

21. Gustavo, P. et al. Pattern recognition receptors and the host cell death molecular machinery. (2018). https://www.frontiersin.org/articles/10.3389/fimmu.2018.02379/full

22. Benjamin, Bonavida. “Regulation of T. cells in cancer by nitric oxide Regulation of T cells in cancer by nitric oxide. (2021). https://www.mdpi.com/2073-4409/10/10/2655

23. rzyna., “The role of different immunocompetent cell populations in the pathogenesis of head and neck cancer—regulatory mechanisms of pro-and anti-cancer activity and their impact on immunotherapy The role of different immunocompetent cell populations in the pathogenesis of head and neck cancer—regulatory mechanisms of pro-and anti-cancer activity and their …. (2023). https://www.mdpi.com/2072-6694/15/6/1642

24. Deng, Q. Y. G. L. Z. R. L. Z. Z. K. L. R. L. et al NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver. (2019). https://www.sciencedirect.com/science/article/pii/S0304383518306451

25. Amani, A. A., Murilo, H. S. D. L. & Tarcio, T. B. The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis. (2020). https://www.frontiersin.org/articles/10.3389/fimmu.2020.00883/full

26. Christine, R. et al. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. (2019). https://www.sciencedirect.com/science/article/pii/S0301472X19311282

27. Zebin, D. et al. CHIP protects against septic acute kidney injury by inhibiting NLRP3-mediated pyroptosis. (2023). https://www.cell.com/iscience/fulltext/S2589-0042(23)01839-4

28. Tetsuro, K. et al. Inflammation-induced tumorigenesis and metastasis. (2021). https://www.mdpi.com/1422-0067/22/11/5421

29. Shumei, Y., Hua, W., Yongcheng, H. & Yi, Miao. “Knockdown of L. inhibits the progression of lung cancer by regulating T.-κB pathways and N. inflammasome Knockdown of LRRK2 inhibits the progression of lung cancer by regulating TLR4/NF-κB pathways and NLRP3 inflammasome. (2023). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636582/

30. Sang, H. K. et al. The role of microglial LRRK2 in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction. (2023). https://www.biorxiv.org/content/10.1101/2023.04.03.535418.abstract

Obesity

Almost half of US adults are obese or severely obese. Lack of physical activity, unhealthy eating behavior, and, in some cases, genetics contribute to obesity. Halia is developing investigational treatments to combat obesity.

Learn More

Pain and Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is an autoimmune condition where the immune system—normally the body's defender against infection and disease—attacks its own tissues. This results in pain, swelling, stiffness, and loss of joint function. Halia is developing an investigational treatment for both RA and post-surgical pain.

Learn More

Alzheimer's Disease

Alzheimer’s disease involves parts of the brain that control memory, language, problem-solving, and other thinking abilities. It can seriously affect a person’s ability to carry out daily activities. Halia is developing a potentially relevant pathway and investigational treatment for Alzheimer’s.

Learn More

Parkinson's Disease

Parkinson’s disease is a progressive disorder that affects the nervous system and the parts of the body controlled by the nerves. Tremors, stiffness, or slowing of movement are typical symptoms. Halia is developing a potential brain-penetrant compound to treat the disease.

Learn More

Cancer

Cancer occurs when normal cells become cancerous cells that multiply and spread. Cancer is the second most common cause of death in the U.S. However, fewer people die of cancer now than 20 years ago19. Halia is developing potential pathways to prevent the onset of cancer.
Learn More